Cost-Effectiveness Analysis of Apixaban Versus Rivaroxaban for Prevention of Stroke in Patients with Non-Valvular Atrial Fibrillation in Spain
Abstract
Authors
C. Canal Fontcuberta G. Escolar Albaladejo L. Betegón Nicolás M. de Salas-Cansado D. Rubio-Rodríguez C. Rubio-Terrés